Actively Recruiting

Phase Not Applicable
Age: 18Years - 79Years
All Genders
NCT05585190

Stand up for Your Health With a Sit-stand Desk

Led by Medical College of Wisconsin · Updated on 2026-05-04

198

Participants Needed

1

Research Sites

255 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

More than 84 million - or 1 out of every 3 U.S. adults - have prediabetes, a condition that if not treated often leads to type 2 diabetes within five years. Average medical expenditures among diabetics are about 2.3 times higher than expenditures for people without diabetes. Physical inactivity and elevated body mass index (BMI) are major risk factors for the disease. Sedentary behavior is becoming increasingly prevalent with the growth of a 'work from home' culture, most recently driven by the COVID-19 pandemic. Cross-sectional epidemiologic data report significant associations between high amounts of sedentary (sitting) time and prevalent cardiovascular disease and diabetes. In our pilot study of 15 subjects with sedentary office jobs, 6 months of sit-stand desk use resulted in a 23% improvement in insulin resistance, most substantial in those who decreased daily sitting by over 90 minutes/day. Additional improvements in vascular endothelial function and triglyceride levels were seen without any change in exercise activity, step counts, or body weight. These findings not only corroborate epidemiologic findings on this topic but suggest causality and warrant a randomized control trial. The investigators hypothesize that adult subjects at-risk for diabetes will improve insulin sensitivity, metabolic and vascular (endothelial) health with a sit-stand desk intervention at work (whether in the office or at home), in the context of a randomized, controlled trial. The investigators will randomize 198 sedentary office workers with a BMI≥25 at risk for type 2 diabetes mellitus in a 1:1:1 ratio of three groups: (a) sit-stand desk intervention targeting 2 hours standing per day; (b) sit-stand desk intervention targeting 3 hours standing per day; or (c) control arm over 6 months. The block randomization design will allow for important dose-response analyses. The investigators will objectively quantify standing time, sedentary time, sedentary bouts, daily steps, and exercise activity times using a compact and re-usable accelerometer that adheres to the subject's thigh. This will provide objective assessments of activity levels and sedentary times for 7 full days each at baseline, 3 and 6 months. The device is equipped with an inclinometer to classify posture (sitting verses standing).

CONDITIONS

Official Title

Stand up for Your Health With a Sit-stand Desk

Who Can Participate

Age: 18Years - 79Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Overweight or obese with a body mass index (BMI) of 25 kg/m2 or higher
  • Employees with sedentary jobs sitting at a desk for at least 75% of an 8-hour or longer workday
  • At risk for diabetes, defined as either having prediabetes (HbA1c 5.7% to 6.4% or fasting glucose 100 to 125 mg/dL) or at least one additional risk factor such as age 45 or older, family history of diabetes, physical inactivity, history of gestational diabetes, hypertension, dyslipidemia, or belonging to specified ethnic groups
Not Eligible

You will not qualify if you...

  • Established cardiovascular disease such as heart attack, coronary stent, bypass surgery, cardiac transplant, or angina
  • Established congestive heart failure or cardiomyopathy
  • Established peripheral vascular disease
  • Diabetes diagnosis (HbA1c 6.5% or higher or on diabetes medications or insulin)
  • Chronic musculoskeletal disorders affecting lower limbs or regular use of walking aids
  • Neuropathy of any cause
  • Positional fainting or history of orthostatic symptoms
  • Working less than 4 days per week at a single office or work-from-home location
  • Current use of a standing desk at work
  • Tobacco use within the last 12 months
  • Current illicit drug use or excessive alcohol use
  • Steroid use for 21 or more days per year
  • Fasting triglycerides 500 mg/dL or higher
  • Thyroid disease
  • Uncontrolled or untreated high blood pressure (over 150/90 mm Hg)
  • Pregnant, breastfeeding, or planning pregnancy in the next 6 months
  • LDL cholesterol 190 mg/dL or higher
  • Currently enrolled in or planning to start a diet or weight loss program in the next 6 months
  • Non-English speaker

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Medical College of Wisconsin

Milwaukee, Wisconsin, United States, 53226

Actively Recruiting

Loading map...

Research Team

J

Jacquelyn Kulinski, MD

CONTACT

R

Ryan Kacala

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here